How should a patient with erythrocytosis, high hematocrit, low blood urea nitrogen (BUN), and elevated creatinine be managed?

Management of Erythrocytosis with Elevated Hematocrit, Low BUN, and Elevated Creatinine

The primary approach is to first identify the underlying cause of erythrocytosis through targeted diagnostic workup, then manage based on whether this represents primary polycythemia vera, secondary erythrocytosis, or a renal pathology—with therapeutic phlebotomy reserved only for severe symptomatic cases (hemoglobin >20 g/dL and hematocrit >65% with hyperviscosity symptoms), while avoiding routine phlebotomy due to stroke risk.

Initial Diagnostic Approach

The combination of erythrocytosis with low BUN but elevated creatinine is unusual and requires systematic evaluation:

Key Laboratory Tests to Order

• JAK2 mutation testing - This is critical to differentiate polycythemia vera from secondary causes 1
• Serum erythropoietin (EPO) level - Low/normal EPO suggests polycythemia vera; elevated EPO indicates secondary erythrocytosis 2, 3
• Arterial oxygen saturation and carboxyhemoglobin - To exclude hypoxia-driven erythrocytosis 2
• Iron studies (serum ferritin, transferrin saturation) - Iron deficiency increases stroke risk even with erythrocytosis 1
• Peripheral blood smear - Assess red cell morphology 1

Evaluate the Renal Function Pattern

The low BUN with elevated creatinine is atypical and suggests:

• Reduced protein intake relative to renal function (BUN reflects both GFR and dietary protein) 4
• Possible chronic kidney disease with altered urea handling 1
• Need for accurate GFR assessment beyond serum creatinine alone 1

Management Based on Etiology

If Cyanotic Heart Disease or Secondary Erythrocytosis

Avoid aggressive phlebotomy - This is a Class III recommendation (harm) 1:

• Most cyanotic patients have compensated erythrocytosis requiring no intervention 1
• Therapeutic phlebotomy only if:
  • Hemoglobin >20 g/dL AND
  • Hematocrit >65% AND
  • Symptomatic hyperviscosity (headache, poor concentration) AND
  • No dehydration present 1
• When phlebotomy is necessary: Remove 1 unit blood with equal volume replacement using dextrose or saline 1
• Target hematocrit: ~60% for symptomatic relief 2

Critical warning: Repeated routine phlebotomies cause iron depletion, decreased oxygen-carrying capacity, and increased stroke risk 1

If Post-Renal Transplant or Renal Parenchymal Disease

First-line treatment: ACE inhibitors or angiotensin II receptor blockers (ARBs) 5:

• These effectively lower hematocrit in post-transplant erythrocytosis 2, 6
• Mechanism: May induce apoptosis in erythroid precursors 2
• However, monitor closely given the elevated creatinine - check renal function 1-2 weeks after initiation 7

Alternative: Theophylline - Reduces adenosine-mediated erythropoietin synthesis 2, 6

Renal Function Monitoring Considerations

Given the elevated creatinine, cautious medication management is essential 1:

• Avoid nephrotoxic drugs: NSAIDs, certain antibiotics 7, 1
• Ensure adequate hydration - Dehydration worsens renal function in erythrocytosis 1
• If using ACE inhibitors/ARBs:
  • Acceptable creatinine increase: Up to 50% above baseline or to 266 μmol/L (3 mg/dL), whichever is smaller 7
  • If creatinine increases >100% or >310 μmol/L (3.5 mg/dL), stop the medication and seek specialist advice 7
• Hydrate before any contrast procedures - Cyanotic/erythrocytosis patients are at high risk for contrast-induced nephropathy 1

Iron Repletion Strategy

Check and correct iron deficiency 1:

• Iron-deficient red cells have reduced oxygen-carrying capacity and deformability
• This increases stroke and vascular complication risk
• Oral iron: Monitor hemoglobin closely as it can cause rapid red cell mass increase 1
• IV iron: Use pulsed dosing if oral intolerance 1
• Discontinue once ferritin/transferrin saturation normalizes 1

Common Pitfalls to Avoid

1. Do NOT perform routine phlebotomy without meeting strict criteria - this causes more harm than benefit 1

2. Do NOT assume dehydration - Always confirm volume status before attributing elevated hematocrit to dehydration alone 1

3. Do NOT ignore iron deficiency - Even with high hematocrit, iron deficiency is dangerous 1

4. Do NOT use medications affecting renal function carelessly - ACE inhibitors, diuretics, NSAIDs require cautious monitoring in this setting 7, 1

5. Do NOT delay specialist referral - Patients with erythrocytosis and renal dysfunction should be managed by specialists experienced in these conditions 1

Specific Treatment Algorithm

Step 1: Confirm true erythrocytosis (not just hemoconcentration from dehydration)

Step 2: Order JAK2 mutation and serum EPO level

Step 3: Assess iron stores and correct deficiency

Step 4: If symptomatic hyperviscosity with Hgb >20 g/dL and Hct >65%:

• Single phlebotomy with volume replacement
• Not repeated routine phlebotomy

Step 5: If secondary erythrocytosis with renal involvement:

• Trial ACE inhibitor/ARB with close creatinine monitoring
• Alternative: Theophylline

Step 6: Monitor renal function closely, avoid nephrotoxins, ensure hydration

Step 7: Refer to hematology and nephrology specialists for ongoing management